Estefania Moreno GUILLÉN

Title: Estefania Moreno GUILLÉN: Innovator in Peptide Compounds

Introduction

Estefania Moreno GUILLÉN is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of peptide compounds. Her work focuses on reducing the side effects associated with CB1 receptor agonists, which are crucial in various therapeutic applications.

Latest Patents

Estefania holds a patent for "Peptide compounds for reducing side effects of CB1 receptor agonists." This invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, along with processes for their obtention and therapeutic indications. This patent highlights her innovative approach to addressing challenges in pharmacology.

Career Highlights

Throughout her career, Estefania has been associated with esteemed institutions such as the University of Barcelona and Universitat Pompeu Fabra. Her academic background and research endeavors have positioned her as a key figure in her field.

Collaborations

Estefania has collaborated with notable researchers, including Vicent Casadó Burillo and Rafael Maldonado López. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Estefania Moreno GUILLÉN exemplifies the spirit of innovation in the pharmaceutical industry. Her work on peptide compounds demonstrates her commitment to advancing medical science and improving patient outcomes.